SEGMENTED INFORMATION (Details) (USD $) In Thousands, unless otherwise specified	1 Months Ended	2 Months Ended	3 Months Ended		4 Months Ended	6 Months Ended		2 Months Ended	3 Months Ended	6 Months Ended		2 Months Ended	3 Months Ended	6 Months Ended		1 Months Ended	2 Months Ended	3 Months Ended	4 Months Ended	1 Months Ended	4 Months Ended	1 Months Ended	4 Months Ended
	Apr. 30, 2011	Jun. 30, 2011	Jun. 30, 2012	Mar. 31, 2012	Apr. 30, 2011	Jun. 30, 2012 Segment	Dec. 31, 2011	Jun. 30, 2011 Medical Device Technologies	Jun. 30, 2012 Medical Device Technologies	Jun. 30, 2012 Medical Device Technologies	Dec. 31, 2011 Medical Device Technologies	Jun. 30, 2011 Licensed Technologies	Jun. 30, 2012 Licensed Technologies	Jun. 30, 2012 Licensed Technologies	Dec. 31, 2011 Licensed Technologies	Apr. 30, 2011 Predecessor	Jun. 30, 2011 Predecessor	Mar. 31, 2011 Predecessor	Apr. 30, 2011 Predecessor	Apr. 30, 2011 Predecessor Medical Device Technologies	Apr. 30, 2011 Predecessor Medical Device Technologies	Apr. 30, 2011 Predecessor Licensed Technologies	Apr. 30, 2011 Predecessor Licensed Technologies
SEGMENTED INFORMATION
Number of reportable segments						2
Segmented information
Revenue		$ 36,970	$ 61,338			$ 121,889		$ 35,902	$ 56,523	$ 111,147		$ 1,068	$ 4,815	$ 10,742		$ 21,674			$ 80,266	$ 16,365	$ 69,198	$ 5,309	$ 11,068
Cost of products sold		26,934	27,322			52,006		26,934	27,322	52,006						8,291			32,219	8,291	32,219
License and royalty fees		50	63			174						50	63	174					68				68
Gross margin		9,986	33,953			69,709		8,968	29,201	59,141		1,018	4,752	10,568		13,383			47,979	8,074	36,979	5,309	11,000
Research and development		2,829	2,423			4,408										1,156			5,686
Selling, general and administration		12,781	17,784			35,431										6,191			24,846
Depreciation and amortization		5,690	8,428			17,451										3,088			14,329
Write-down of assets held for sale																570			570
Write-down of property, plant and equipment			692			865													215
Operating income (loss)		(11,314)	4,626			11,554										2,378			2,333
Other expenses		(2,428)	(3,920)			(8,061)										(2,573)			(10,939)
Income (loss) before reorganization items and income taxes		(13,742)	706			3,493										(195)			(8,606)
Reorganization items																329,826			321,084
Gain on extinguishment of debt and settlement of other liabilities																67,307			67,307
Loss before income taxes		(13,742)	706			3,493										396,938			379,785
Income tax expense (recovery)	(600)	506	3,654		300	6,440										(581)			267
Net (loss) income		(14,248)	(2,948)	1		(2,947)										397,519	(14,248)	(18,001)	379,518
Royalty revenue received from BSC as a percent of total revenue for the period			6.00%			7.00%										24.00%	0.00%		12.00%
Total assets
Total assets			626,016			626,016	608,106		548,329	548,329	522,120		77,687	77,687	85,986
Capital expenditures
Capital expenditures		$ 385	$ 480			$ 892		$ 288	$ 480	$ 892		$ 97				$ 142			$ 945	$ 113	$ 621	$ 29	$ 324